News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Quick Survey For GBM patients

Al's Comment:

Now that Optune is FDA approved for both newly diagnosed and recurrent GBMs, we would assume all Glioblastoma patients would at least be offered it as a choice but I am hearing from some patients who were never told about it.  If you (or a loved one) were diagnosed since Jan 1, 2016 with a GBM, please take this quick 1 question survey!  Then we can figure out if more education is needed!

Posted on: 01/24/2017


 If you or a loved one was diagnosed with a Glioblastoma, please take our quick 1 question survey at:




Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557